Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
4.080
-0.280 (-6.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Nutriband Employees
Nutriband had 13 employees as of January 31, 2022. The number of employees increased by 8 or 160.00% compared to the previous year.
Employees
13
Change (1Y)
8
Growth (1Y)
160.00%
Revenue / Employee
$155,521
Profits / Employee
-$526,703
Market Cap
45.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortress Biotech | 186 |
| Barinthus Biotherapeutics | 130 |
| AlloVir | 112 |
| Omega Therapeutics | 94 |
| Lucid Diagnostics | 70 |
| Kezar Life Sciences | 58 |
| Q32 Bio | 37 |
| enVVeno Medical | 31 |
NTRB News
- 17 days ago - Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - GlobeNewsWire
- 24 days ago - Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology - GlobeNewsWire
- 7 weeks ago - Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application - Accesswire
- 2 months ago - Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - Accesswire
- 2 months ago - Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 - Accesswire
- 3 months ago - Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology - Accesswire
- 3 months ago - Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch - Accesswire
- 3 months ago - Nutriband Inc. Authorizes $1M Share Buyback Program - Accesswire